D16 - What’s new in industry and science? Part 1

Conference Hall B2


Gabrielle Wiederkehr (ACCESS Regulatory Consulting GmbH, Switzerland) and Takuya Kumamoto (Hiroshima University, Japan)


Short oral presentations selected from submitted abstracts


14:30 – 14:40 Introduction by the chairs

  1. 14:40 – 14:50 Quality assessment of Amoxicillin oral products in the National Capital District, Papua New Guinea
    Beverley Dawn Glass (James Cook University, Australia)
  2. 14:50 – 15:00 Diclofenac orodispersible films by hot melt ram extrusion 3d printing
    Garba Mohammed Khalid (University of Milan, Italy)
  3. 15:00 – 15:10 Impact of artificial intelligence and machine learning on drug research and development
    Safa Damiati (King Abdulaziz University, Kingdom of Saudi Arabia)
  4. 15:10 – 15:20 Progress and prospect of nanogel in skin cancer
    Prashant Sahu (Dr Harisingh Gour Central University, India)
  5. 15:20 – 15:30 Eyelid skin application extends delivery of drugs in the eyeball
    Gerard Lee Lo See (Josai University, Japan)
  6. 15:30 – 15:40 Pharmaceutical compounding: An alternative treatment option in psoriasis
    Yashoda Pramar (PCCA Research and Development, USA)
  7. 15:40 – 15:50 Developments in pharmaceutical green chemistry
    Lilian Azzopardi (University of Malta, Malta)

15:50 – 16:10 Coffee/tea break


  1. 16:10 – 16:20 Drug-related problems among breast cancer patients receiving chemotherapy in northern Nigeria
    Hadiza Usman Maaji (Ahmadu Bello University Zaria, Nigeria)
  2. 16:20 – 16:30 Clinical and humanistic impact of a community pharmacist-led adherence service: Adherenciamed
    Tamara Peiró (General Pharmaceutical Council of Spain, Spain)
  3. 16:30 – 16:40 Adherence to antihypertensive medications in patients attending public hospitals in Kano
    Umar Idris Ibrahim (Bayero University Kano, Nigeria)

16:40 – 16:55 Q & A and conclusion by the chairs

16:55 – 17:00 Room refresh                                                     

Learning Objectives

At the end of this section, participants will be able to:

  1. List innovations and new discoveries in industry and pharmaceutical science
  2. State new initiatives in industry and pharmaceutical science that can be adapted based on presented information
  3. Share actionable application of results of recent studies in industry and pharmaceutical science.


Type of session: Knowledge based